Antiparasitic activities of novel, orally available fumagillin analogs.
暂无分享,去创建一个
Anjan Debnath | Joseph L DeRisi | Jiri Gut | Nathan Wilson | Paolo A Centrella | J. Derisi | J. Gut | P. Rosenthal | P. Chiang | J. McKerrow | C. Arico-Muendel | Paolo A. Centrella | Steve Skinner | J. Svendsen | B. Morgan | A. Debnath | Christopher Arico-Muendel | James H McKerrow | Philip J Rosenthal | Gary K O'Donovan | Peter K Chiang | Steven R Skinner | Barry A Morgan | Brooke D Contonio | Gary O'Donovan | Christopher L Paradise | Barbara Sluboski | Jennifer L Svendsen | Kerry F White | B. Sluboski | Christopher L. Paradise | Kerry F. White | N. Wilson | Gary O’Donovan | Nathan Wilson
[1] D. Ingber,et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.
[2] J. Smith,et al. Molecular cloning, sequencing, deletion, and overexpression of a methionine aminopeptidase gene from Saccharomyces cerevisiae. , 1992, The Journal of biological chemistry.
[3] X Li,et al. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] Y. Chang,et al. Evidence that the human homologue of a rat initiation factor-2 associated protein (p67) is a methionine aminopeptidase. , 1996, Biochemical and biophysical research communications.
[5] K. Biemann,et al. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. , 1997, Chemistry & biology.
[6] W. Bornmann,et al. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Widom,et al. Structure of human methionine aminopeptidase-2 complexed with fumagillin. , 1998, Science.
[8] Eric C. Griffith,et al. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] G A Petsko,et al. Chemistry and biology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] X. Su,et al. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. , 2002 .
[11] C. D. Thompson,et al. A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[13] Jun O. Liu,et al. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity , 2006, Proceedings of the National Academy of Sciences.
[14] B. Lefkove,et al. Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors , 2007, Expert review of anti-infective therapy.
[15] P. Chiang,et al. Total syntheses of (+/-)-ovalicin, C4(S *)-isomer, and its C5-analogs and anti-trypanosomal activities. , 2008, Bioorganic & medicinal chemistry.
[16] Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity. , 2009, Bioorganic & medicinal chemistry letters.
[17] Jun O. Liu,et al. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. , 2009, Chemistry & biology.